-
-
Dignify Therapeutics Announces Jeff Welch as Chief Operating Officer
RESEARCH TRIANGLE PARK, NC (June 12, 2025) – Dignify Therapeutics (Dignify), a pharmaceutical and medical device development company focused on restoring bowel and bladder control for elderly and neurologically impaired individuals, today announced that Jeff Welch has been named as Chief Operating Officer. Mr. Welch comes to Dignify with over two decades of diverse business…
-
Bolstering Bowel And Bladder Control With Dignify Therapeutics’ Karl Thor
Source: Drug Delivery Leader
-
Dignify Therapeutics Highlights Clinical Development Plans at the BIO CEO & Investor Conference
Research Triangle Park, NC – February 14, 2025 – Dignify Therapeutics, a biotechnology company dedicated to restoring voluntary bowel and bladder function in patients with neurological conditions, presented its clinical development plans for its lead assets, DTI-117 and DTI-301, at the BIO CEO & Investor Conference held in New York on February 10-11, 2025. During…
-
Dignify Therapeutics Selected as a Praxis SCI Accelerate Company
Company RESEARCH TRIANGLE PARK, NC (October 22, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, has been selected as a participating company in the Praxis Spinal Cord Injury (SCI) Accelerate Program. SCI Accelerate is a commercialization program ‘geared towards healthcare companies with a product ready to launch into…
-
Dignify to highlight recent accomplishments at the 2024 BIO Investor Forum
RESEARCH TRIANGLE PARK, NC (October 15, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Tony DiTonno, CEO and Executive Chairman, will provide a status update on the company’s two lead drug development programs on Wednesday, Oct 16, as part of the BIO Investor Forum in San…
-
Dignify Therapeutics to Participate in the BIO Investor Forum, October 2024
RESEARCH TRIANGLE PARK, NC (October 1, 2024) – Dignify Therapeutics (Dignify), a specialty pharma company focused on resorting bowel and bladder function in patients with neurological diseases will be a presenting company at the BIO Investor Forum in San Francisco at the Fairmount Hotel at 11:15am on October 16, 2024. Dignify is developing two products…
-
Dignify Therapeutics welcomes leading healthcare entrepreneurs Howard Palefsky and Neil Kurtz, MD to its Board of Directors
RESEARCH TRIANGLE PARK, NC (October 10, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Howard Palefsky and Dr. Neil Kurtz have joined Dignify’s Board of Directors. Mr. Palefsky has a broad range of experience as a Board Member and Advisor in the healthcare and biomedical industries,…
-
Dignify Therapeutics awarded two new research grants from the National Institutes of Health (NIH)
RESEARCH TRIANGLE PARK, NC (September 19, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, recently received two significant research grants from the NIH. These grants add to the previous $20 million in research funding the company has received to advance multiple therapeutics for bladder and bowel disorders. Grants…
-
Dignify Therapeutics welcomes leading spinal injury expert Alexander “Sasha” Rabchevsky PhD, to its Scientific Advisory Board
RESEARCH TRIANGLE PARK, NC (August 5, 2024) – Dignify Therapeutics (Dignify), a leading developer of therapies for bladder and bowel dysfunction, announced that Dr. Rabchevsky has joined Dignify’s Scientific Advisory Board (SAB). Dr. Rabchevsky is currently Professor of Physiology and inaugural faculty member of the Spinal Cord & Brain Injury Research Center at the University…
